Filing Details
- Accession Number:
- 0001562180-22-002871
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-22 19:51:00
- Reporting Period:
- 2022-03-21
- Accepted Time:
- 2022-03-22 19:51:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1770121 | Sana Biotechnology Inc. | SANA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1309988 | Y Patrick Yang | C/O Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 Seattle WA 98102 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-21 | 28,000 | $7.30 | 174,250 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $7.14 to $7.40, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
Billionaire Hedge Funds
